Etienne Canouï

ORCID: 0000-0003-0612-5691
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • COVID-19 Clinical Research Studies
  • Antibiotic Use and Resistance
  • Infectious Diseases and Tuberculosis
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Identification and Susceptibility Testing
  • Pneumonia and Respiratory Infections
  • Infectious Encephalopathies and Encephalitis
  • Herpesvirus Infections and Treatments
  • Ocular Infections and Treatments
  • COVID-19 and Mental Health
  • Orthopedic Infections and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Ocular Diseases and Behçet’s Syndrome
  • Antifungal resistance and susceptibility
  • HIV Research and Treatment
  • Infection Control and Ventilation
  • Long-Term Effects of COVID-19
  • Pharmacovigilance and Adverse Drug Reactions
  • Mycobacterium research and diagnosis
  • Influenza Virus Research Studies
  • Mosquito-borne diseases and control
  • Antimicrobial Resistance in Staphylococcus
  • Amoebic Infections and Treatments

Assistance Publique – Hôpitaux de Paris
2016-2025

Maternité Port Royal
2021-2025

Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale
2017-2024

Hôpital Cochin
2017-2024

Sorbonne Université
2012-2024

Université Paris Cité
2017-2023

Hôpital Beaujon
2015-2023

Pitié-Salpêtrière Hospital
2022

Observatoire de la Côte d’Azur
2022

Hôpital Pasteur
2022

ObjectivesIntestinal carriage with extended spectrum β-lactamase Enterobacteriaceae (ESBL-E) and carbapenemase-producing (CPE) can persist for months. We aimed to evaluate whether oral antibiotics followed by faecal microbiota transplantation (FMT) eradicate intestinal ESBL-E/CPE.MethodsRandomized, open-label, superiority trial in four tertiary-care centres (Geneva (G), Paris (P), Utrecht (U), Tel Aviv (T)). Non-immunocompromised adult patients were randomized 1: 1 either no intervention...

10.1016/j.cmi.2018.12.009 article EN cc-by-nc-nd Clinical Microbiology and Infection 2019-01-05
Stéphane Bretagne Karine Sitbon Marie Desnos‐Ollivier Dea Garcia‐Hermoso Valérie Letscher‐Bru and 95 more Sophie Cassaing Laurence Millon Florent Morio Jean‐Pierre Gangneux Lilia Hasseine Loïc Favennec Estelle Cateau Éric Bailly Maxime Moniot Julie Bonhomme Nicole Desbois-Nogard Taïeb Chouaki A. Paugam Bernard Bouteille Marc Pihet Frédéric Dalle O. Éloy Milène Sasso Magalie Demar Patricia Mariani‐Kurkdjian Vincent Robert Olivier Lortholary Françoise Dromer Céline Damiani Hervé Dupont Julien Maizel Anne Totet Jean-Philippe Bouchara Anne Pauline Bellanger Ana Berceanu Jean Christophe Navellou Émeline Scherer Philippe Abboud Christine Aznar Denis Blanchet Félix Djossou Sophie Cayot Cyril Garrouste O. Lesens Cécile Moluçon Céline Nourrisson Philippe Poirier Éloïse Bailly Louise Basmaciyan Bouhemad Belaid Mathieu Blot Denis Caillot Pierre‐Emmanuel Charles Jean‐Pierre Quenot E. Amazan É. Baubion André Cabié Cyrille Chabartier C. Deligny Violaine Emal Olivier Flechelle Yves Hatchuel Yohann Le Govic H. Merle Charline Miossec Jean-Marie Turmel Ruddy Valentino Marie-Fleur Durieux Pascal Turlure Victor Mercier M. Gari-Toussaint Karine Risso Loïc Simon Cédric Bretonnière D. Boutoille Thomas Gastinne Karim Lakhal É. Launay Thierry Lepoivre Pierre Péterlin Fanny Rialland Patrice Le Pape Etienne Canouï Naïma Dahane Solène Kerneis Cécile Angebault M.-E. Bougnoux Nadia Guennouni Fanny Lanternier Bennedicte Neven Mehdi Oualha Anne Scemla Emilie Sitterlé Felipe Suárez Julie Toubiana Stéphane Bonacorci Alexandre Alanio Anne Bergeron Blandine Denis Maud Gits‐Muselli

The French National Reference Center for Invasive Mycoses and Antifungals leads an active sustained nationwide surveillance program on probable proven invasive fungal diseases (IFDs) to determine their epidemiology in France. Between 2012 2018, a total of 10,886 IFDs were recorded. incidence increased slightly over time (2.16 2.36/10,000 hospitalization days, P = 0.0562) relation with increase fungemia (1.03 1.19/10,000, 0.0023), while that other remained stable. proportion ≥65-year-old...

10.1128/mbio.00920-22 article EN mBio 2022-05-02

Abstract Background The development of chatbot artificial intelligence (AI) has raised major questions about their use in healthcare. We assessed the quality and safety management suggested by Chat Generative Pre-training Transformer 4 (ChatGPT-4) real-life practice for patients with positive blood cultures. Methods Over a 4-week period tertiary care hospital, data from consecutive infectious diseases (ID) consultations first culture were prospectively provided to ChatGPT-4. Data requested...

10.1093/cid/ciad632 article EN Clinical Infectious Diseases 2023-10-12

Abstract Background The optimal duration of antimicrobial therapy for urinary tract infections (UTIs) in men remains controversial. Methods To compare 7 days to 14 total antibiotic treatment febrile UTIs men, this multicenter randomized, double-blind. placebo-controlled noninferiority trial enrolled 282 from 27 centers France. Men were eligible if they had a UTI and urine culture showing single uropathogen. Participants treated with ofloxacin or third-generation cephalosporin at day 1, then...

10.1093/cid/ciad070 article EN Clinical Infectious Diseases 2023-02-11

Abstract Background The 2011 4th European Conference on Infections in Leukemia (ECIL4) guidelines recommend antibiotics de-escalation/discontinuation selected febrile neutropenia (FN) patients. We aimed to assess the impact of an antimicrobial stewardship (AMS) program based these use and clinical outcomes high-risk FN Methods conducted observational study hematology department Cochin University Hospital Paris, France. An ECIL4-based de-escalation discontinuation strategy was implemented...

10.1186/s13756-022-01084-0 article EN cc-by Antimicrobial Resistance and Infection Control 2022-03-26

Human immunodeficiency virus controllers (HICs) form a heterogeneous group of patients with regard to formal definitions, immunologic characteristics, and changes over time in viral load.The HICs undetectable load ([uHICs] ie, for whom had never been detected routine assays; n = 52) were compared 178 blips during the follow up (bHICs). Clinical ultrasensitive HIV-ribonucleic acid (RNA) HIV-deoxyribonucleic (DNA) loads, HIV1-Western blot profiles, immune parameters analyzed.Relative bHICs,...

10.1093/ofid/ofx064 article EN cc-by-nc-nd Open Forum Infectious Diseases 2017-01-01

Healthcare workers (HCWs) have paid a heavy toll during the coronavirus disease 2019 (COVID-19) outbreak. Routes of transmission remain to be fully understood.This prospective study compared 1500-bed adult and 600-bed pediatric setting tertiary-care university hospital located in central Paris. From 24 February until 10 April 2020, all symptomatic HCWs were screened for severe acute respiratory syndrome 2 (SARS-CoV-2) on nasopharyngeal swab. positive questioned their profession, symptoms,...

10.1093/cid/ciaa977 article EN other-oa Clinical Infectious Diseases 2020-07-09

Objectives. The treatment of long-term intravenous catheter-related bloodstream infections (LTIVC-related BSI) often requires catheter removal or a conservative using intra-catheter locks, with 50-60% success rate. We previously demonstrated the synergistic effect combination gentamicin and EDTA-Na2 against bacterial biofilms. performed phase 1/2 clinical trial to assess tolerance efficacy genta-EDTA-Na2 locks for LTIVC-related BSI. Methods. Prospective study including adult patients...

10.1101/2025.03.21.25324295 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2025-03-21

Abstract Background Excess of acute kidney injury (AKI) secondary to the association vancomycin plus piperacillin is debated. Objectives To detect a signal for an increased risk AKI with and combination compared other vancomycin-based regimens. Methods Using VigiBase, WHO global database individual case safety reports (ICSR) from 1997 2019, we conducted disproportionality analysis comparing reporting cases between different regimens (vancomycin piperacillin, cefepime or meropenem). take into...

10.1093/jac/dkab003 article EN Journal of Antimicrobial Chemotherapy 2021-01-06
Léa Poussier Alexandra Mailles Pierre Tattevin J.‐P. Stahl Pierre Fillâtre and 95 more Sophie Abgrall Laurent Argaud X. Argémi Nathalie Asseray Guillaume Baille Aurélie Baldolli Julien Biberon Charlotte Biron Geneviève Blanchet-Fourcade Mathieu Blot Anne Bonnetain Élisabeth Botelho-Nevers Frédéric Bourdain D. Boutoille Hélène Brasme Cédric Bruel Fabrice Bruneel Rodolphe Buzelé Etienne Canouï Philippe Casenave Bernard Castan Charles Cazanave Céline Cazorla Thibault Challan-Belval P. Chavanet Catherine Chirouze Tomasz Chroboczek Johan Courjon T. de Broucker Arnaud De La Blanchardière Étienne de Montmollin Thècle Degroote Marine Delaroche É. Denes Colin Deschanvres Capucine Diard‐Detoeuf Aurélien Dinh Olivier Épaulard Pierre Fillâtre E. Forestier Thibault Fraisse Marie Froidure Benjamin Gaborit Amandine Gagneux-Brunon Nicolas Gaillard Arnaud Galbois Mathieu Godement François Goehringer Simon Gravier Valentin Greigert I. Gueït Thomas Guimard Carole Henry Maxime Hentzien Jean-Étienne Herbrecht Pierre Jaquet Fanny Jommier Lydie Katchatourian Solene Kerneis Jessica Krause Manuela Le Cam Marion Le Maréchal G. Le Moal Paul Le Turnier R. Lecomte Anne-Sophie Lecompte Romain Lefaucheur Stéphanie Lejeune François-Xavier Lescure Olivier Lesieur P. Lesprit Guillaume Louis Christelle Lucas Rafaël Mahieu Alain Makinson Guillaune Marc A. Maria Nathalie Marin Aurélie Martin Guillaume Martin‐Blondel M. Martinot Alexandre Mas Philippe Mateu Morgan Matt Laurence Maulin F. Méchaï Jean‐Paul Mira Eugénie Mutez Jérémie Orain Anne Schieber-Pachart Nathalie Pansu S. Patrat-Delon Patricia Pavèse Hélène Pelerin Véronique Pelonde-Erimée

10.1016/j.cmi.2024.03.017 article EN Clinical Microbiology and Infection 2024-03-26
Marion Le Maréchal Alexandra Mailles Arnaud Seigneurin Pierre Tattevin J.‐P. Stahl and 95 more Olivier Épaulard Sophie Abgrall Laurent Argaud X. Argémi Nathalie Asseray Guillaume Baille Aurélie Baldolli Thomas Baudry Julien Biberon Charlotte Biron Geneviève Blanchet-Fourcade Mathieu Blot Mickaël Bonnan Anne Bonnetain Élisabeth Botelho-Nevers Frédéric Bourdain D. Boutoille Hélène Brasme Cédric Bruel Fabrice Bruneel Rodolphe Buzelé Etienne Canouï Philippe Casenave Bernard Castan Charles Cazanave Céline Cazorla Thibault Challan-Belval P. Chavanet Catherine Chirouze Johan Courjon Daniel Silva T. de Broucker Arnaud De La Blanchardière Étienne de Montmollin Thècle Degroote Marine Delaroche É. Denes Colin Deschanvres Capucine Diard‐Detoeuf Aurélien Dinh Olivier Épaulard Pierre Fillâtre E. Forestier T. Fraisse Marie Froidure Benjamin Gaborit Amandine Gagneux-Brunon Nicolas Gaillard Arnaud Galbois Mathieu Godement François Goehringer Pascale Goubin Simon Gravier Valentin Greigert I. Gueït Thomas Guimard Carole Henry Maxime Hentzien Jean-Étienne Herbrecht Pierre Jaquet Fanny Jomier Lydie Khatchatourian Solen Kernéis Jessica Krause Morgane Le Bras Manuela Le Cam Marion Le Maréchal G. Le Moal Paul Le Turnier R. Lecomte Anne-Sophie Lecompte Romain Lefaucheur Stéphanie Lejeune François-Xavier Lescure Olivier Lesieur P. Lesprit Guillaume Louis Christelle Lucas Rafaël Mahieu Alain Makinson Guillaune Marc A. Maria Nathalie Marin Aurélie Martin Guillaume Martin‐Blondel M. Martinot Alexandre Mas Philippe Mateu Morgan Matt Laurence Maulin F. Méchaï Jean‐Paul Mira Eugénie Mutez Jérémie Orain Anne Pachart

New diagnostic tools have been developed to improve the diagnosis of infectious encephalitis. Using a prospective cohort encephalitis patients, our objective was identify possible clusters patients with similar patterns among unknown cause (EUC) and describe what extent patient's initial presentation may be predictive etiology, particularly herpes simplex virus (HSV) varicella-zoster (VZV).The National Cohort Infectious Encephalitis in France is an ongoing study implemented 2016. Patients...

10.1093/cid/ciaa598 article EN Clinical Infectious Diseases 2020-05-19

This study aimed at characterizing the pharmacokinetics (PK) of oral levofloxacin in adult patients order to optimize dosing scheme and explore PK/pharmacodynamics (PD) bone joint infections (BJIs).From November 2015 December 2019, all hospitalized Cochin Hospital, treated with who had least one dosage for therapeutic drug monitoring were included. PK was described using non-linear mixed-effect modelling. In a subgroup BJIs, association between PK, MIC isolated pathogen clinical outcome...

10.1093/jac/dkac031 article EN Journal of Antimicrobial Chemotherapy 2022-01-26

Pelvic bone and/or soft tissue sarcoma removal surgeries are associated with a high rate of surgical site infection (SSI). The recommended antibiotic prophylaxis (ABP) duration is 24-48 h. We aimed to assess the impact extended ABP (5 days) on SSI and describe microbiology in pelvic sarcomas.We retrospectively included all consecutive patients who underwent surgery between January 2010 June 2020.We analyzed 146 (45, 31%) or (101, 69%). Sixty (41%) developed SSI. occurred 13/28 (46.4%) group...

10.1002/jso.27271 article EN Journal of Surgical Oncology 2023-04-03
Coming Soon ...